Leisure time activity equivalent to less than 1.5 hours’ walking time per week may be enough to substantially reduce the risk for neuropathy and nephropathy in type 2 diabetes, say Danish researchers. Medscape Medical News
Tag: Diabetes & Endocrinology
New Approaches for Diabetic Keratopathy in the Eye?
Findings also have implications for treating other diabetes-related wound healing conditions such as foot ulcers. Medscape Medical News
Aging and Type 1 Diabetes: ‘Complete Picture’ 40 Years On
The Diabetes Control and Complications Trial (DCCT) and its follow-on observational study EDIC continue to provide new insights into type 1 diabetes as the study participants age. Medscape Medical News
Alarm Bells Ring for Eye Issues in Kids With Type 2 Diabetes
Annual screening with fundus photography could allow for early detection and treatment of diabetic retinopathy in children diagnosed with type 2 diabetes. Medscape Medical News
Aflibercept Not for Prevention in Early Diabetic Retinopathy
‘Preventive treatment with anti-VEGF [such as aflibercept] for eyes with nonproliferative diabetic retinopathy generally is not a strategy that is warranted,’ says study investigator. Medscape Medical News
Eye Check Important Before Starting Semaglutide for Diabetes
Meta-analysis finds small increased risk of retinopathy worsening after starting injectable semaglutide. Medscape Medical News
Diabetes Link Found for Fuchs Corneal Endothelial Dystrophy
In a case-control study of about 149,000 US military veterans, risk factors for Fuchs endothelial corneal dystrophy included diabetes, female sex, European ancestry, and other comorbidities. First Look
New Consensus on Thyroid Eye Disease Prompts Some Debate
The joint statement from the American Thyroid Association and European Thyroid Association offers appraisal of recent thyroid eye disease management for endocrinologists, with some debate on treatment. Medscape Medical News
Treatment Type Doesn’t Affect Risk of Retinal Detachment in DR
Giving intravitreal injection only, or laser only, makes no difference to risk of later retinal detachment in patients with proliferative diabetic retinopathy, nor does 6-months plus loss to follow-up. Medscape Medical News
Type 1 Diabetes Complication Risk Rises With A1c, Duration
Study following people for over 30 years from the time of type 1 diabetes diagnosis finds increasing risk of complications with A1c levels above a certain threshold, increasing duration of disease. Medscape Medical News
Bevacizumab First Matches Aflibercept for Diabetic Macular Edema
Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy. Medscape Medical News
Diabetic Retinopathy Risk, Severity Show Socioeconomic Links
Low income and type of health insurance was associated with an increased prevalence of medical risk factors for diabetic retinopathy as well as the risk for vision-threatening disease. First Look
Retinopathy Risk in Kids Higher in Type 2 Than Type 1 Diabetes
Children diagnosed with type 2 diabetes appear significantly more likely to develop retinopathy and other ocular complications than children diagnosed with type 1 diabetes. Medscape Medical News
Retinopathy Risk Higher in Young-Onset T2D, More So in Men
Men diagnosed with type 2 diabetes by the age of 40 years appear significantly more likely to develop retinopathy than men who are diagnosed at an older age. Medscape Medical News
Alarming Number of Youths With Type 2 Diabetes Have Eye Damage
Diabetic retinopathy, a complication that can eventually lead to sight loss, was found in nearly half of young adults with type 2 diabetes. WebMD Health News
Adding Statins to Steroids in Thyroid Eye Disease Improves Outcomes
The drugs were linked to improvements in Graves’ orbitopathy, even in people without high LDL-cholesterol; anti-inflammatory effects a possible explanation. Medscape Medical News
Do Anti-VEGF Injections for Diabetic Retinopathy Impact Mortality?
A signal for higher mortality in patients with diabetic retinopathy using anti-VEGF inhibitors was seen in a new study, but this needs to be looked at more rigorously, says an expert. Medscape Medical News
Even Inactive Thyroid Eye Disease Adversely Impacts Patients
Patients with inactive thyroid eye disease continue to have eye symptoms as well as poor mental health and quality of life. Medscape Medical News
Only 1 in 3 US Adults With Diabetes Receive ADA-Recommended Care
In 2017-2018, only one in three received all of five care elements recommended by the American Diabetes Association. Medscape Medical News
Surgery Equals Drug Tx for Bleeding in Diabetic Retinopathy
A comparison of vitrectomy and anti-VEGF injections to treat vitreous hemorrhage in patients with proliferative diabetic retinopathy shows the pros and cons of each, but effects are similar. Medscape Medical News